Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Cardiol Therapeutics Inc. CRDL

Full chart Compare
Set alert

Price alert · CRDL

All alert types
1.01 USD 0.00 (+0.00%)

At closeNov 5, 2026, 8:58 AM EST

1.02 +0.01 +0.99%

Pre-market · Nov 5, 8:58 AM ET

0.9951 Day range 1.06
0.88 52-week range 2.34
YTD
+5.87%
1 year
-7.34%

Financial health

Altman Z-Score

5.22 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 5
  • P/E 1
  • P/B 1

Valuation

P/E -3.4×
FY 2017: -64.4×FY 2018: -7.7×FY 2019: -8.7×FY 2020: -4.0×FY 2021: -3.2×FY 2022: -1.4×FY 2023: -2.5×FY 2024: -3.6×FY 2025: -3.4×
FY 2017 5y median -3.2× FY 2025
P/S 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 1623×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
P/B 6.4×
FY 2017: 37.5×FY 2018: 5.5×FY 2019: 8.1×FY 2020: 6.3×FY 2021: 1.3×FY 2022: 1.1×FY 2023: 2.5×FY 2024: 5.3×FY 2025: 6.4×
FY 2017 5y median 2.5× FY 2025
P/FCF -4.8×
FY 2017: -80.9×FY 2018: -11.3×FY 2019: -10.0×FY 2020: -9.1×FY 2021: -4.3×FY 2022: -1.6×FY 2023: -2.9×FY 2024: -5.3×FY 2025: -4.8×
FY 2017 5y median -4.3× FY 2025
EV/EBITDA -2.7×
FY 2017: -69.7×FY 2018: -14.7×FY 2019: -10.7×FY 2020: -4.3×FY 2021: -0.7×FY 2022: 0.0×FY 2023: -1.8×FY 2024: -2.8×FY 2025: -2.7×
FY 2017 5y median -1.8× FY 2025
EV/Sales 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 278×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
FCF Yield -21.0%
FY 2017: -1.2%FY 2018: -8.8%FY 2019: -10.0%FY 2020: -11.0%FY 2021: -23.3%FY 2022: -63.2%FY 2023: -35.1%FY 2024: -19.0%FY 2025: -21.0%
FY 2017 5y median -23.3% FY 2025

Profitability

Gross Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -179.9%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -49092.4%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -40170.9%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
ROE -189.2%
FY 2017: -58.2%FY 2018: -71.4%FY 2019: -71.9%FY 2020: -122.1%FY 2021: -32.8%FY 2022: -59.3%FY 2023: -75.1%FY 2024: -148.3%FY 2025: -189.2%
FY 2017 5y median -75.1% FY 2025
ROIC -190.6%
FY 2017: -52.2%FY 2018: -32.8%FY 2019: -73.3%FY 2020: -121.0%FY 2021: -40.0%FY 2022: -79.1%FY 2023: -79.1%FY 2024: -161.8%FY 2025: -190.6%
FY 2017 5y median -79.1% FY 2025
ROA -143.2%
FY 2017: -51.6%FY 2018: -64.4%FY 2019: -68.1%FY 2020: -101.9%FY 2021: -28.5%FY 2022: -49.9%FY 2023: -57.8%FY 2024: -115.1%FY 2025: -143.2%
FY 2017 5y median -57.8% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: -100.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 FY 2025
Operating Income 14.8%
FY 2017: 0.0%FY 2018: -365.0%FY 2019: -47.4%FY 2020: -49.1%FY 2021: -88.2%FY 2022: 0.2%FY 2023: 26.3%FY 2024: -79.2%FY 2025: 14.8%
FY 2017 FY 2025
EPS (diluted) 23.5%
FY 2017: 0.0%FY 2018: -802.9%FY 2019: 19.7%FY 2020: -30.2%FY 2021: -5.8%FY 2022: 32.9%FY 2023: 10.2%FY 2024: -15.9%FY 2025: 23.5%
FY 2017 FY 2025
Free Cash Flow 4.8%
FY 2017: 0.0%FY 2018: -725.5%FY 2019: -8.2%FY 2020: 22.3%FY 2021: -157.0%FY 2022: -15.8%FY 2023: 7.5%FY 2024: 0.6%FY 2025: 4.8%
FY 2017 FY 2025

Financial Health

Current Ratio 4.2×
FY 2017: 14.1×FY 2018: 11.2×FY 2019: 20.8×FY 2020: 5.9×FY 2021: 7.5×FY 2022: 6.3×FY 2023: 4.4×FY 2024: 4.5×FY 2025: 4.2×
FY 2017 5y median 4.5× FY 2025
Quick Ratio 4.2×
FY 2017: 14.1×FY 2018: 8.3×FY 2019: 11.8×FY 2020: 5.8×FY 2021: 7.5×FY 2022: 6.3×FY 2023: 4.4×FY 2024: 4.5×FY 2025: 4.2×
FY 2017 5y median 4.5× FY 2025
Debt / Equity 0.0×
FY 2017: 0.1×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
Net Debt / EBITDA 0.6×
FY 2017: 1.4×FY 2018: 2.3×FY 2019: 0.7×FY 2020: 0.9×FY 2021: 3.4×FY 2022: 1.9×FY 2023: 1.7×FY 2024: 0.8×FY 2025: 0.6×
FY 2017 5y median 1.7× FY 2025
Interest Coverage 0.0×
FY 2017: -26.2×FY 2018: -11.1×FY 2019: -17544×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31